Nectar Life Sciences Income Statement
Quarterly
Yearly
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| EBITDA | 113 | 170 | 0 |
| EBIT | 27 | 113 | 0 |
| Earning Per Share | -3 | 1 | -1 |
| Expenses | 1,434 | 1,510 | 1,471 |
| Net Profit | -73 | 25 | -24 |
| Net Profit Margin | -4 | 1 | -1 |
| Operating Profit Margin | 6 | 9 | 6 |
| Profit Before Tax | -85 | 34 | -42 |
| Dividends Per Share | 0 | 0 | 0 |
| Operation Revenue | 1,547 | 1,680 | 1,567 |
Peer Comparison (in ₹.Cr.)
| Company | Year | EBIT | EBITDA | Net Profit | Net Worth | Profit Before Tax |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 80.62 | NA | 86.80 | |
| 2023 | 0 | 0 | 377.40 | NA | 868.45 | |
| 2023 | 0 | 0 | 447.69 | NA | 716.49 | |
| 2023 | 0 | 0 | 4,470.30 | NA | 6,011.50 | |
| 2023 | 0 | 0 | 8,560.84 | NA | 9,408.43 |
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2018 | 2019 | 2020 | 2020 | 2020 | |
|---|---|---|---|---|---|
| Operating Activities | 65 | 239 | 285 | 285 | 285 |
| Investing Activities | -29 | -26 | -33 | -33 | -33 |
| Financing Activities | -40 | -201 | -252 | -252 | -252 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -4 | 12 | -0 | -0 | -0 |
Peer Comparison (in ₹.Cr.)
| Company | Year | Operating Activities | Investing Activities | Financing Activities | Net Cash Flow |
|---|---|---|---|---|---|
| 2022 | -17.75 | 18.85 | -5.82 | -4.72 | |
| 2020 | 1,392.41 | -783.52 | -444.66 | 164.23 | |
| 2020 | 1,468.84 | 1,106.99 | -890.58 | 1,685.25 | |
| 2016 | 3,262.60 | -2,039.40 | -1,700.10 | -476.90 | |
| 2018 | 3,907.15 | -3,370.81 | -1,539.26 | -1,002.92 |
Financials
All values are in Rs Cr